HK1226106A1 - 針對膀胱癌的dna甲基化生物標誌物 - Google Patents

針對膀胱癌的dna甲基化生物標誌物

Info

Publication number
HK1226106A1
HK1226106A1 HK16114360A HK16114360A HK1226106A1 HK 1226106 A1 HK1226106 A1 HK 1226106A1 HK 16114360 A HK16114360 A HK 16114360A HK 16114360 A HK16114360 A HK 16114360A HK 1226106 A1 HK1226106 A1 HK 1226106A1
Authority
HK
Hong Kong
Prior art keywords
bladder cancer
dna methylation
methylation biomarkers
biomarkers
dna
Prior art date
Application number
HK16114360A
Other languages
English (en)
Inventor
Su Sheng-Fang
Liang Gangning
Jones Peter
SIEGMUND Kimberly
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of HK1226106A1 publication Critical patent/HK1226106A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK16114360A 2013-05-10 2016-12-16 針對膀胱癌的dna甲基化生物標誌物 HK1226106A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361821838P 2013-05-10 2013-05-10

Publications (1)

Publication Number Publication Date
HK1226106A1 true HK1226106A1 (zh) 2017-09-22

Family

ID=51867787

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16109319.7A HK1221264A1 (zh) 2013-05-10 2016-08-04 針對膀胱癌的 甲基化生物標誌物
HK16114360A HK1226106A1 (zh) 2013-05-10 2016-12-16 針對膀胱癌的dna甲基化生物標誌物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK16109319.7A HK1221264A1 (zh) 2013-05-10 2016-08-04 針對膀胱癌的 甲基化生物標誌物

Country Status (5)

Country Link
US (2) US10570455B2 (zh)
EP (1) EP2994545B1 (zh)
CN (1) CN105705653A (zh)
HK (2) HK1221264A1 (zh)
WO (1) WO2014183093A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201632629A (zh) * 2015-01-14 2016-09-16 臺北醫學大學 用於癌症診斷與預後的方法
WO2017171548A1 (en) * 2016-04-01 2017-10-05 Nanomed Diagnostics B.V. Detection of cancer in urine
DE102016005947B3 (de) 2016-05-16 2017-06-08 Dimo Dietrich Verfahren zur Abschätzung der Prognose und zur Prädiktion des Ansprechens auf eine Immuntherapie von Patienten mit malignen Erkrankungen
US11685955B2 (en) 2016-05-16 2023-06-27 Dimo Dietrich Method for predicting response of patients with malignant diseases to immunotherapy
BR112019022360A2 (pt) * 2017-05-18 2020-05-19 Genomic Health Inc métodos para monitorar um paciente com câncer de bexiga e para tratar um paciente com câncer de bexiga, sistema para quantificar a metilação de dna, cartucho, kit e composição
EP3729440A1 (en) * 2017-12-22 2020-10-28 VIB vzw Predicting chronic allograft injury through ischemia-induced dna methylation
EP3880847A2 (en) * 2018-11-16 2021-09-22 Oslo Universitetssykehus HF Methods and compositions for characterizing bladder cancer
CN111533795B (zh) * 2019-03-12 2020-10-30 上海交通大学医学院附属新华医院 Hla-a2限制性膀胱癌肿瘤新抗原肽序列及其应用
CN110343762A (zh) * 2019-06-06 2019-10-18 宽盈医疗科技(上海)有限公司 膀胱癌标志物组及其应用
CN110343600A (zh) * 2019-06-06 2019-10-18 宽盈医疗科技(上海)有限公司 膀胱癌诊断系统、试剂组合和检测尿液中目的基因甲基化水平的方法
CN110923322B (zh) * 2019-12-26 2020-12-01 广州市基准医疗有限责任公司 膀胱癌相关的dna甲基化生物标志物组合和检测试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6292169B1 (en) 1998-02-13 2001-09-18 Kabushiki Kaisha Toshiba Information input apparatus
US8617809B2 (en) * 2005-02-14 2013-12-31 The Johns Hopkins University Neoplasia screening compositions and methods of use
WO2008009365A2 (en) * 2006-07-18 2008-01-24 Epigenomics Ag A method for determining the methylation rate of a nucleic acid
US20120252020A1 (en) 2007-08-17 2012-10-04 Predictive Biosciences, Inc. Screening Assay for Bladder Cancer
US20110028333A1 (en) * 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
EP2427571A2 (en) * 2009-05-05 2012-03-14 Katholieke Universiteit Leuven Hepatocellular carcinoma
WO2010149782A1 (en) * 2009-06-26 2010-12-29 Epigenomics Ag Methods and nucleic acids for analysis of bladder cell proliferative disorders
BR112014002975A2 (pt) 2011-08-08 2017-03-01 Caris Life Sciences Luxembourg Holdings S A R L composições de biomarcador e métodos
WO2014019595A1 (en) 2012-08-01 2014-02-06 Universität Konstanz Method for the detection of dna methylation and hydroxymethylation

Also Published As

Publication number Publication date
EP2994545B1 (en) 2019-03-20
WO2014183093A1 (en) 2014-11-13
WO2014183093A9 (en) 2014-12-11
EP2994545A1 (en) 2016-03-16
EP2994545A4 (en) 2017-01-11
CN105705653A (zh) 2016-06-22
US10570455B2 (en) 2020-02-25
HK1221264A1 (zh) 2017-05-26
US11566293B2 (en) 2023-01-31
US20160177398A1 (en) 2016-06-23
US20200347459A1 (en) 2020-11-05

Similar Documents

Publication Publication Date Title
HK1217218A1 (zh) 結直腸癌生物標誌物
HK1226106A1 (zh) 針對膀胱癌的dna甲基化生物標誌物
HK1210832A1 (zh) 利用生物標誌物進行癌症診斷
EP2931922A4 (en) PERSONALIZED BIOMARKERS FOR CANCER
SG11201506891YA (en) Pre-eclampsia biomarkers
SG11201510210XA (en) Methods for detecting prostate cancer
IL233803A0 (en) Monocyte biomarkers for cancer detection
EP2831270B8 (en) Biomarker for bladder cancer
EP3066474A4 (en) Bladder Carcinoma Biomarkers
HK1216779A1 (zh) 用於癌症治療的預測性生物標記物
EP2861766A4 (en) METHYLATION BIOMARKERS FOR BREAST CANCER
GB201322800D0 (en) Prostate cancer biomarkers
GB201321474D0 (en) Novel biomarkers
HK1224010A1 (zh) 卵巢癌生物標誌物
GB201500584D0 (en) Cancer biomarkers
GB201317621D0 (en) Kidney disease biomarker
GB201309426D0 (en) Biomarkers
GB201316526D0 (en) Biomarkers
GB201308077D0 (en) Biomarkers
EP3015476A4 (en) Tumor biomarker
GB201316524D0 (en) Biomarkers
GB201312638D0 (en) Biomarkers
GB201306339D0 (en) Biomarkers for prognosis
EP3033617A4 (en) Biomarkers for prostate cancer
GB201322783D0 (en) Biomarkers